{
    "nctId": "NCT02666690",
    "briefTitle": "Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast",
    "officialTitle": "Study of the Intra-patient Variability of the Quantitative Parameters of Tumor Perfusion Evaluated With Ultrasound Contrast",
    "overallStatus": "COMPLETED",
    "conditions": "GIST Metastatic Cancer, Breast Metastatic Cancer, Kidney Metastatic Cancer, Colon Metastatic Cancer, Rectal Metastatic Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "N/A",
    "enrollmentCount": 59,
    "primaryOutcomeMeasure": "Variability of quantitative parameters of Tumor Perfusion Evaluated With Ultrasound Contrast",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patient being treated at IGR for metastatic cancer by anti-angiogenic (s) drug (s) in the following indications:\n\n   * Gastrointestinal sarcoma (GIST)\n   * Breast Cancers\n   * Kidney Cancers\n   * Colorectal Cancers\n   * Melanoma\n\n   These anti-angiogenic drugs are used alone or in combination: Bevacizumab (Avastin), imatinib (Gleevec), Sorafenib (Nexavar), sunitinib (Sutent), Everolimus (Afinitor) Temsirolimus (Torisel), ... (non exhaustive list).\n2. With at least one clearly identified metastatic tumor lesion (and accessible to ultrasound for acquisition 3 minutes without losing the target), measuring more than 2 cm, less than 50% of the volume is necrotic.\n\n   Metastatic lesions are:\n   * Liver (30 patients)\n   * Or outside the liver (30 patients)\n3. Physiological Age: 18-80 years\n4. performance status \\<2\n5. Patient information and signature of informed consent\n\nExclusion Criteria:\n\n1. Background known hypersensitivity to sulfur hexafluoride or one of the components,\n2. recent history of acute coronary syndrome or unstable ischemic heart disease,\n3. Acute heart failure, heart failure stage III or IV, or severe rhythm disorders,\n4. uncontrolled hypertension or severe pulmonary hypertension,\n5. Right-Left Shunt,\n6. Respiratory Distress Syndrome,\n7. Patient without vascularized tumor (without contrast enhancement)\n8. patient whose antiangiogenic has already started,\n9. Pregnant woman likely to be or breastfeeding,\n10. Persons deprived of liberty or under guardianship,\n11. Unable to submit to medical monitoring of the trial for geographical, social or psychological reasons",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}